Bispecifics Before CAR-T May Be Best-Bet Sequence for Large B-Cell Lymphoma

By News Health
1 hour Ago

(MedPage Today) — The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal treatment sequence than BsAb after CAR-T in patients with relapsed or refractory large B-cell lymphoma…

Source link : https://www.medpagetoday.com/hematologyoncology/lymphoma/119225

Author :

Publish date : 2025-12-30 21:30:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Liver Cancer Treatment Landscape Shifts Rapidly, but Best Sequencing Still Unclear

In a Tumultuous Year, U.S. Health Policy Has Been Greatly Reshaped Under RFK Jr.

Circadian Rhythms and Dementia; How ADHD Drugs Work; Can Alzheimer's Be Reversed?

New Clues to Transdifferentiation in T-Cell Acute Lymphoblastic Leukemia

75% of Adults Have Obesity; Gestational Diabetes Rates Rising; Oprah Praises GLP-1s

I Was Wrong About RFK Jr.